Villamil, Alejandra
Universidade Federal do Rio Grande · Universidade Federal do Rio Grande do Sul · University of Miami · Hospital Italiano de Buenos Aires · Ege University · Hospital de Clínicas de Porto Alegre · Azienda Ospedaliero-Universitaria di Modena · Liver Institute Northwest · University of California Davis Medical Center · University of Milano-Bicocca · University of California, Davis
3 papers on CoChatORCID 0000-0001-7152-0976
Most cited papers
- Verified
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kowdley, K. V., Bowlus, C. L., Levy, C., Akarca, U. S., Alvares-da-Silva, M. R., Andreone, P., Arrese, M., Corpechot, C., Francque, S. M., Heneghan, M. A., et al. (2024) · New England Journal of Medicine
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 314
- Verified
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
Hirschfield, G. M., Bowlus, C. L., Mayo, M. J., Kremer, A. E., Vierling, J. M., Kowdley, K. V., Levy, C., Villamil, A., Ladrón de Guevara Cetina, A. L., Janczewska, E., et al. (2024) · New England Journal of Medicine
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 286
- Verified
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Corpechot, C., Lemoinne, S., Soret, P.-A., Hansen, B., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Pares, A., Olivas, I., et al. (2024) · Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 94
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free